CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Phase III Trial Comparing Nanoparticle-based Paclitaxel With Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Patients With Early Breast Cancer (GeparSepto)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01583426
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:36.951065+00:00
Published At: 2020-08-06T00:00:00+00:00
Record Updated At: 2020-08-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Tubular Breast Cancer Stage II", "Mucinous Breast Cancer Stage II", "Breast Cancer Female NOS", "Invasive Ductal Breast Cancer", "Tubular Breast Cancer Stage III", "HER-2 Positive Breast Cancer", "Inflammatory Breast Cancer Stage IV", "Inflammatory Breast Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-08-06"
protocolSection.identificationModule.nctId: "NCT01583426"
protocolSection.identificationModule.officialTitle: "A Randomized Phase III Trial Comparing Nanoparticle-based Paclitaxel With Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Patients With Early Breast Cancer (GeparSepto)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.